DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+19.07%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.81B
AUM Growth
+$2.81B
(-0.26%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
28.25%
Holding
132
New
16
Increased
23
Reduced
29
Closed
16
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$54.6M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$54.4M |
| 3 |
Tandem Diabetes Care
TNDM
|
$49.7M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$47.4M |
| 5 |
Sarepta Therapeutics
SRPT
|
$39.1M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$93.4M |
| 2 |
DexCom
DXCM
|
$46M |
| 3 |
Natera
NTRA
|
$39.5M |
| 4 |
Glaukos
GKOS
|
$36.1M |
| 5 |
Centene
CNC
|
$32.5M |
Sector Composition
| 1 | Healthcare | 74.9% |
| 2 | Financials | 2.36% |
